# Tango Therapeutics, Inc.: Form 8-K, filed May 23, 2024

- Company: [Tango Therapeutics, Inc.](/companies/tngx.md) (CIK 1819133)
- Form: 8-K
- Filed: 2024-05-23
- Accepted by EDGAR: May 23, 2024, 07:18 ET
- Period: 2024-05-23
- Accession: 0001193125-24-145434
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1819133/000119312524145434/d823505d8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1819133/000119312524145434/

## Items reported

- Item 7.01: Regulation FD disclosure
- Item 8.01: Other events
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1819133/000119312524145434/d823505d8k.htm

Filed May 23, 2024.
Source: SEC EDGAR, the filing index for accession 0001193125-24-145434. Last ingested by Listed: Nov 15, 2026, 01:16 ET. No prices; not investment advice.
